BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 17340610)

  • 21. Aripiprazole augmentation in clozapine-associated obsessive-compulsive symptoms.
    Villari V; Frieri T; Fagiolini A
    J Clin Psychopharmacol; 2011 Jun; 31(3):375-6. PubMed ID: 21532362
    [No Abstract]   [Full Text] [Related]  

  • 22. Randomized, placebo-controlled trial of cognitive-behavioral therapy alone or combined with sertraline in the treatment of pediatric obsessive-compulsive disorder.
    Storch EA; Bussing R; Small BJ; Geffken GR; McNamara JP; Rahman O; Lewin AB; Garvan CS; Goodman WK; Murphy TK
    Behav Res Ther; 2013 Dec; 51(12):823-9. PubMed ID: 24184429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aripiprazole in schizophrenia patients with comorbid obsessive-compulsive symptoms: an open-label study of 15 patients.
    Glick ID; Poyurovsky M; Ivanova O; Koran LM
    J Clin Psychiatry; 2008 Dec; 69(12):1856-9. PubMed ID: 19026264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aripiprazole augmentation of clomipramine-refractory obsessive-compulsive disorder.
    Friedman S; Abdallah TA; Oumaya M; Rouillon F; Guelfi JD
    J Clin Psychiatry; 2007 Jun; 68(6):972-3. PubMed ID: 17592930
    [No Abstract]   [Full Text] [Related]  

  • 25. Successful Treatment Response with Aripiprazole Augmentation of SSRIs in Refractory Obsessive-Compulsive Disorder in Childhood.
    Akyol Ardic U; Ercan ES; Kutlu A; Yuce D; Ipci M; Inci SB
    Child Psychiatry Hum Dev; 2017 Oct; 48(5):699-704. PubMed ID: 27812841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary retention with sertraline, haloperidol, and clonazepam combination.
    Benazzi F
    Can J Psychiatry; 1998 Dec; 43(10):1051-2. PubMed ID: 9868574
    [No Abstract]   [Full Text] [Related]  

  • 27. Optimal treatment for obsessive compulsive disorder: a randomized controlled feasibility study of the clinical-effectiveness and cost-effectiveness of cognitive-behavioural therapy, selective serotonin reuptake inhibitors and their combination in the management of obsessive compulsive disorder.
    Fineberg NA; Baldwin DS; Drummond LM; Wyatt S; Hanson J; Gopi S; Kaur S; Reid J; Marwah V; Sachdev RA; Pampaloni I; Shahper S; Varlakova Y; Mpavaenda D; Manson C; O'Leary C; Irvine K; Monji-Patel D; Shodunke A; Dyer T; Dymond A; Barton G; Wellsted D
    Int Clin Psychopharmacol; 2018 Nov; 33(6):334-348. PubMed ID: 30113928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials.
    Dold M; Aigner M; Lanzenberger R; Kasper S
    Int J Neuropsychopharmacol; 2013 Apr; 16(3):557-74. PubMed ID: 22932229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological treatment of obsessive-compulsive disorder.
    Simpson HB
    Curr Top Behav Neurosci; 2010; 2():527-43. PubMed ID: 21309125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antipsychotic augmentation of selective serotonin reuptake inhibitors in resistant tic-related obsessive-compulsive disorder in children and adolescents: a naturalistic comparative study.
    Masi G; Pfanner C; Brovedani P
    J Psychiatr Res; 2013 Aug; 47(8):1007-12. PubMed ID: 23664673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial.
    Pediatric OCD Treatment Study (POTS) Team
    JAMA; 2004 Oct; 292(16):1969-76. PubMed ID: 15507582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aripiprazole augmentation in highly treatment-resistant obsessive-compulsive disorder - experience from a specialty clinic in India.
    Hegde A; Kalyani BG; Arumugham SS; Narayanaswamy JC; Math SB; Reddy YC
    Int J Psychiatry Clin Pract; 2017 Mar; 21(1):67-69. PubMed ID: 27629160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful aripiprazole augmentation in a child with drug-resistant obsessive-compulsive disorder.
    Oztürk M; Coskun M
    J Clin Psychopharmacol; 2009 Dec; 29(6):607-9. PubMed ID: 19910732
    [No Abstract]   [Full Text] [Related]  

  • 34. Aripiprazole-associated leukopenia with coadministration of fluoxetine: a case report.
    Huang LC; Chiang KT
    J Clin Psychopharmacol; 2011 Jun; 31(3):376-7. PubMed ID: 21532363
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pharmacological treatment of children and adolescents with OCD].
    Thomsen H
    Ugeskr Laeger; 2001 Jul; 163(27):3763-8. PubMed ID: 11466982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.
    Simpson HB; Foa EB; Liebowitz MR; Huppert JD; Cahill S; Maher MJ; McLean CP; Bender J; Marcus SM; Williams MT; Weaver J; Vermes D; Van Meter PE; Rodriguez CI; Powers M; Pinto A; Imms P; Hahn CG; Campeas R
    JAMA Psychiatry; 2013 Nov; 70(11):1190-9. PubMed ID: 24026523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Systematic Review of Evidence-based Treatment Strategies for Obsessive- compulsive Disorder Resistant to first-line Pharmacotherapy.
    Albert U; Marazziti D; Di Salvo G; Solia F; Rosso G; Maina G
    Curr Med Chem; 2018; 25(41):5647-5661. PubMed ID: 29278206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological treatment strategies in obsessive compulsive disorder: A cross-sectional view in nine international OCD centers.
    Van Ameringen M; Simpson W; Patterson B; Dell'Osso B; Fineberg N; Hollander E; Hranov L; Hranov G; Lochner C; Karamustafalioglu O; Marazziti D; Menchon JM; Nicolini H; Pallanti S; Stein DJ; Zohar J
    J Psychopharmacol; 2014 Jun; 28(6):596-602. PubMed ID: 24429223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis.
    Veale D; Miles S; Smallcombe N; Ghezai H; Goldacre B; Hodsoll J
    BMC Psychiatry; 2014 Nov; 14():317. PubMed ID: 25432131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quetiapine augmentation of serotonin reuptake inhibitors in obsessive-compulsive disorder.
    Mohr N; Vythilingum B; Emsley RA; Stein DJ
    Int Clin Psychopharmacol; 2002 Jan; 17(1):37-40. PubMed ID: 11800505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.